These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2977760)
1. Expression of major histocompatibility complex class II antigen on target cells in autoimmune endocrine diseases. Hanafusa T Nihon Naibunpi Gakkai Zasshi; 1988 Dec; 64(12):1228-32. PubMed ID: 2977760 [No Abstract] [Full Text] [Related]
2. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Bottazzo GF; Pujol-Borrell R; Hanafusa T; Feldmann M Lancet; 1983 Nov; 2(8359):1115-9. PubMed ID: 6138647 [TBL] [Abstract][Full Text] [Related]
3. [Aberrant expression of HLA-DR antigens and autoimmune phenomenon in endocrine diseases]. Gutiérrez C; Fernández-Cruz E Rev Clin Esp; 1986 Apr; 178(6):255-8. PubMed ID: 3487815 [No Abstract] [Full Text] [Related]
4. The complex role of epithelial cell MHC class II antigen expression in autoimmune endocrine disease. Davies TF Autoimmunity; 1990; 8(2):87-9. PubMed ID: 2104190 [No Abstract] [Full Text] [Related]
6. Class II major histocompatibility complex and organ specific autoimmunity in man. Foulis AK J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837 [TBL] [Abstract][Full Text] [Related]
7. [The HLA system class II. Its implication in auto-immune endocrine diseases]. Saï P; Houssaint E Ann Endocrinol (Paris); 1989; 50(3):237-45. PubMed ID: 2510577 [No Abstract] [Full Text] [Related]
8. Class II antigen expression in autoimmune disease. Taub F Lancet; 1984 Mar; 1(8376):561. PubMed ID: 6142268 [No Abstract] [Full Text] [Related]
9. The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens. Wofsy D; Hardy RR; Seaman WE J Immunol; 1984 Jun; 132(6):2686-9. PubMed ID: 6144707 [No Abstract] [Full Text] [Related]
10. [Autoimmune thyroid diseases. Recent aspects of the pathogenesis and diagnosis]. Scherbaum WA; Berg PA Dtsch Med Wochenschr; 1984 Oct; 109(41):1574-81. PubMed ID: 6236967 [No Abstract] [Full Text] [Related]
11. Autoimmune endocrine disease. Anderson MS Curr Opin Immunol; 2002 Dec; 14(6):760-4. PubMed ID: 12413526 [TBL] [Abstract][Full Text] [Related]
12. HLA class II restriction governing cell cooperation between antigen-specific helper T lymphocytes, B lymphocytes and monocytes for in vitro antibody production to influenza virus. Fischer A; Sterkers G; Charron D; Durandy A Eur J Immunol; 1985 Jun; 15(6):620-6. PubMed ID: 3159585 [TBL] [Abstract][Full Text] [Related]
13. Circulating activated (DR-positive) T lymphocytes in a patient with autoeczematization. Cunningham MJ; Zone JJ; Petersen MJ; Green JA J Am Acad Dermatol; 1986 Jun; 14(6):1039-41. PubMed ID: 2941457 [TBL] [Abstract][Full Text] [Related]
14. [A change in the expression of histocompatibility antigens could lead to autoimmunity]. Pujol-Borrell R; Bottazzo GF; Feldmann M Med Clin (Barc); 1984 Apr; 82(13):594-5. PubMed ID: 6610082 [No Abstract] [Full Text] [Related]
17. Induction of HLA-DR expression on human myoblasts with interferon-gamma. Hohlfeld R; Engel AG Am J Pathol; 1990 Mar; 136(3):503-8. PubMed ID: 2107747 [TBL] [Abstract][Full Text] [Related]
18. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Gruschwitz M; Sepp N; Kofler H; Wick G Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311 [TBL] [Abstract][Full Text] [Related]
19. Characterization of human helper and suppressor factors with special reference to HLA-DR determinants. Lehner T Immunology; 1983 Apr; 48(4):695-702. PubMed ID: 6187668 [TBL] [Abstract][Full Text] [Related]
20. Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Pober JS; Collins T; Gimbrone MA; Libby P; Reiss CS Transplantation; 1986 Feb; 41(2):141-6. PubMed ID: 2935977 [No Abstract] [Full Text] [Related] [Next] [New Search]